Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension

Circulation

Volumn 104, Issue 18, 2001, Pages 2242-2248

  Campbell, Andrew I M ^a   Zhao, Yidan ^a   Sandhu, Reena ^a   Stewart, Duncan J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiogenesis; Endothelium derived factors; Gene therapy; Hypertension, pulmonary; Remodeling

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; LUNG BLOOD VESSEL; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0035975944     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4201.097838     Document Type: Article

References (34)

1. Primary pulmonary hypertension
2. Prognoses of primary pulmonary hypertension and chronic major vessel thromboembolic pulmonary hypertension determined from cumulative survival curves
3. Unpredictable response to vasodilator therapy in primary pulmonary hypertension
4. Intrapulmonary shunting in primary pulmonary hypertension: An observation in two patients treated with epoprostenol sodium
5. Endothelin antagonism with bosentan: A review of potential applications
6. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects
7. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests
8. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide
9. Pathophysiology of primary pulmonary hypertension: From physiology to molecular mechanisms
10. Primary pulmonary hypertension: A vascular biology and translational research "work in progress."
11. Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension
12. Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats
13. Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension
14. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture
15. Bootstrapping regression parameters in multivariate survival analysis
16. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension
17. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat
18. In vivo gene delivery to the pulmonary circulation in rats: Transgene distribution and vascular inflammatory response
19. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
20. Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension
21. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
22. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)
23. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
24. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
25. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor
26. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model
27. Monocrotaline metabolism and distribution in Fisher 344 and Sprague-Dawley rats
28. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium
29. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
30. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
31. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-31
32. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
33. Familial primary pulmonary hypertension (gene PPHI) is caused by mutations in the bone morphogenetic protein receptor-II gene
34. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta